Stati Uniti - inglese - NLM (National Library of Medicine)

apotex corporation - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin 1 g

Stati Uniti - inglese - NLM (National Library of Medicine)

wg critical care, llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - treatment cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) lower respiratory tract infections , including pneumonia and lung abscess, caused by streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis]), staphylococcus aureus (including penicillinase-producing strains), escherichia coli, klebsiella species, haemophilus influenzae, and bacteroides species. (2) urinary tract infections caused by escherichia coli, klebsiella species, proteus mirabilis, morganella morganii, proteus vulgaris and providencia species (including p. rettgeri ). (3) intra-abdominal infections , including peritonitis and intra-abdominal abscess, caused by escherichia coli, klebsiella species, bacteroides species including bacteroides fragilis, and clostridium species. (4) gynecological infections , including endometritis,

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - cefoxitin sodium 1 g - powder for injection - 1 g - active: cefoxitin sodium 1 g - cefoxitin actavis is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. cefoxitin actavis has a high degree of stability against beta-lactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin actavis can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - cefoxitin sodium 2 g - powder for injection - 2 g - active: cefoxitin sodium 2 g - cefoxitin actavis is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. cefoxitin actavis has a high degree of stability against beta-lactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin actavis can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cefoxitin sodium -

Panama - inglese - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios richet s.a. - cefoxitina (cefoxitina sÓdica) - cefoxitina (cefoxitina sÓdica)....1.0 g

Panama - inglese - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

north china pharmaceutical co. ltd - cefoxitina sÓdica - cefoxitina sÓdica....1.0 g

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefoxitin sodium 1.051 g equivalent to cefoxitin 1 g - powder for injection - 1 g - active: cefoxitin sodium 1.051 g equivalent to cefoxitin 1 g - hospira™ cefoxitin sodium powder for injection is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intraabdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. hospira™ cefoxitin sodium powder for injection has a high degree of stability against betalactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. hospira™ cefoxitin sodium powder for injection can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscous perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

Filippine - inglese - FDA (Food And Drug Administration)

h & b pharma international, inc.; distributor: applied pharmaceuticals distribution, inc. - cefoxitin (as sodium) - powder for injection (im/iv) - 1 gram

Filippine - inglese - FDA (Food And Drug Administration)

n/a; importer: ambicare pharmaceuticals inc; distributor: applied pharmaceutical distribution inc - cefoxitin (as sodium) - powder for injection (iv) - 1 g